Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV002132119 | SCV002403202 | benign | not provided | 2023-11-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003025435 | SCV003719342 | likely benign | Inborn genetic diseases | 2022-12-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Genomics, |
RCV003224614 | SCV003920091 | uncertain significance | Zimmermann-Laband syndrome 1; Temple-Baraitser syndrome | 2022-07-22 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature but is present in the Genome Aggregation Database (Highest reported MAF 0.02% (17/68020) (https://gnomad.broadinstitute.org/variant/1-210684089-A-G?dataset=gnomad_r3). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Ce |
RCV002132119 | SCV004125541 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | KCNH1: PP2, BS2 |